RDY 399 (Lansoprazole delayed release 30 mg)

Pill imprint RDY 399 has been identified as Lansoprazole delayed release 30 mg.

Lansoprazole is used in the treatment of barrett's esophagus; gerd; erosive esophagitis; helicobacter pylori infection; gastritis/duodenitis (and more), and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Lansoprazole 30 mg is not a controlled substance under the Controlled Substance Act (CSA).

Lansoprazole delayed release

Imprint:

RDY 399

Strength:

30 mg

Color:

Pink / Black

Shape:

Capsule-shape

Availability:

Rx and/or OTC

Drug Class:

Proton pump inhibitors

Pregnancy Category:

B - No proven risk in humans

CSA Schedule:

Not a controlled drug

Manufacturer:

Dr. Reddy’s Laboratories Inc.

National Drug Code (NDC):

55111-0399

Inactive Ingredients:

ammonia
hydroxypropyl cellulose
low substituted hydroxypropyl cellulose
magnesium carbonate
methacrylic acid - ethyl acrylate copolymer (1:1) type a
polyethylene glycol
polysorbate 80
propylene glycol
shellac
corn starch
sucrose
raw sugar
titanium dioxide
magnesium silicate
gelatin
ferrosoferric oxide
ferric oxide red
ferric oxide yellow
sodium lauryl sulfate

Other Manufacturers / Repackagers:

NDC Code	Manufacturer / Repackager
68084-0468	Amerisource Health Services
63739-0555	McKesson Packaging Services

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.